Efficacy of Palliative Sedation in Advanced Cancer Patients
Author Information
Author(s): Maaike Rijpstra, Kris Vissers, Alazne Belar, Michael van der Elst, Séverine Marie Surges, Claudio Adile, Rocío Rojí, Yasmine Grassi, Ewald Bronkhorst, Sebastiano Mercadante, Lukas Radbruch, Johan Menten, Carlos Centeno, Evelien Kuip, Jeroen Hasselaar
Primary Institution: Radboud University Medical Centre
Hypothesis
The study aims to evaluate the efficacy of palliative sedation by assessing discomfort levels in advanced cancer patients.
Conclusion
Palliative sedation effectively reduces discomfort levels in patients with advanced cancer.
Supporting Evidence
- The mean discomfort score decreased significantly from 9.4 points before sedation to 3.4 points after sedation.
- Discomfort levels were monitored using the Discomfort Scale-Dementia of Alzheimer Type.
- Correlation between discomfort and sedation levels was strong, with an r value of 0.72.
- Continuous sedation was the most common form of sedation used in the study.
Takeaway
This study shows that giving medicine to help patients with severe pain feel more comfortable really works.
Methodology
This was a prospective observational study involving adult patients with advanced malignancies from various palliative care settings across five European countries.
Potential Biases
Potential bias may arise from healthcare professionals' familiarity with patients affecting discomfort assessments.
Limitations
The study only reached 71% of the intended sample size due to challenges in patient recruitment during the COVID-19 pandemic.
Participant Demographics
Participants included 36 males (46%) and 42 females (54%) with a mean age of 69 years.
Statistical Information
P-Value
0.001
Confidence Interval
95% CI 4.8–7.1
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website